While live tweeting the Eye for Pharma Oncology Summit, I noticed a tweet from CNBC's Mike Huckman that Novartis' Afinitor had been approved by the FDA in renal cell cancer:
A short while later it was confirmed on the Novartis website.
Twitter is certainly useful for breaking news. If you're not Twittering yet, check it out. There is even a Pharma wiki created by Jon Richman which is updated regularly as more Pharma join Twitter.